Jensen M D
Endocrine Research Unit, Mayo Foundation, Rochester, MN 55905, USA.
Semin Gastrointest Dis. 1998 Oct;9(4):156-62.
Obesity is a heterogeneous condition. Some individuals suffer severe, life-threatening medical complications as a result of their obesity, whereas others appear to remain healthy for their entire lives despite substantially greater-than-normal amounts of body fat. A personal or family history of adverse health consequences of obesity and an upper-body fat distribution suggests that the patient will have greater health risks from obesity, and these patients stand to benefit more from successful treatment. Therefore, one can justify more aggressive approaches in helping them to make permanent changes in eating and exercise behavior, which are the cornerstones of obesity management. Supplementing these interventions with behavior therapy is necessary for patients unable to make lifestyle changes by themselves. Pharmacotherapy is appropriate for patients with medically complicated obesity in whom other approaches have not succeeded.
肥胖是一种异质性疾病。一些人因肥胖而出现严重的、危及生命的医学并发症,而另一些人尽管体内脂肪量远超正常水平,但似乎一生都保持健康。肥胖对健康产生不良后果的个人或家族史以及上身脂肪分布表明,该患者因肥胖面临的健康风险更大,且这些患者更有可能从成功的治疗中获益。因此,采取更积极的方法来帮助他们在饮食和运动行为上做出永久性改变是合理的,而饮食和运动行为是肥胖管理的基石。对于无法自行改变生活方式的患者,采用行为疗法辅助这些干预措施是必要的。药物治疗适用于患有医学上复杂肥胖症且其他方法均未成功的患者。